title: Are drugs for rare diseases "essential"?
authors.forename: Marcus M
authors.initials: MM
authors.lastname: Reidenberg
mesh_terms: D003362:Cost-Benefit Analysis; D018954:Drugs, Essential; D006801:Humans; D009965:Orphan Drug Production; D035583:Rare Diseases / Q000188:drug therapy*; D040841:Resource Allocation; D012935:Social Justice; D014944:World Health Organization
chemical_list: D018954:Drugs, Essential